Search
for
Sort by
Research 181–210 of 1000+
- Effectiveness of Baricitinib in Alopecia Areata Patients With a Current Episode Lasting Longer Than 8 Years: An Italian Multicenter Real‐Life Experience in the Lazio Region
- 6ER-014 Evaluation of baricitinib in paediatric patients with alopecia areata
- 5PSQ-117 Effectiveness of baricitinib in alopecia areata
- Baricitinib (Olumiant)
- Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Evidence-Based Data on How Long to Treat to Achieve Treatment Response With Baricitinib in Severe Alopecia Areata
- Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
- Újszerű bariátriai bypassműtéttel (SASI) szerzett tapasztalataink
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Update: baricitinib for alopecia areata
- Baricitinib-Loaded Separable Microneedle Array Patch (S-Map) Based on Hyaluronic Acid for Alopecia Areata Therapy
- Clinical and Dermoscopic Evaluation of the Safety and Efficacy of Oral baricitinib (JAK Inhibitor) in Treatment of Localized Vitiligo Either Alone or with Topical Tacrolimus
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata
- Baricitinib-loaded EVs promote alopecia areata mouse hair regrowth by reducing JAK-STAT-mediated inflammation and promoting hair follicle regeneration
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Characterizing Lipid Changes and Use of Lipid-Lowering Medications in Patients With Alopecia Areata Treated With Baricitinib: Integrated Results From the BRAVE-AA1 and -AA2 Clinical Trials
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Alopecia Areata Following the Use of Belimumab in a Patient with Systemic Lupus Erythematosus and Arthritis Who Responded Well to Baricitinib: A Case Report
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Barbering in Laboratory Rodents: Problems and Prospects
- Baricitinib (Olumiant)